Karger Publishers
Browse
OCL_201804022_2_9_Supplementary_Table_1_PDF.PDF (54.16 kB)

Supplementary Material for: Molecular Epidemiology of ALK Rearrangements in Advanced Lung Adenocarcinoma in Latin America

Download (54.16 kB)
dataset
posted on 2018-11-26, 10:48 authored by Arrieta O., Cardona A.F., Bramuglia G., Cruz-Rico G., Corrales L., Martín C., Imaz-Olguín V., Castillo O., Cuello M., Rojas-Bilbao É., Casas G., Fernández C., ArénFrontera O., Denninghoff V., Recondo G., Avilés-Salas A., Mas-Lopez L.-A., Oblitas G., Rojas L., Piottante A., Jiménez-García E., Sánchez-Sosa S., Sáenz-Frias J., Lupera H., Ramírez-Tirado L.A., Vargas C., Carranza H., Astudillo H., Wills L.B., Pichelbaur E., Raez L.E., on behalf of the CLICaP
Objective: Latin American countries are heterogeneous in terms of lung cancer incidence and exposure to potential carcinogens. We evaluated the frequency and clinical characteristics of ALK rearrangements (ALKr) in Latin America. Methods: A total of 5,130 lung cancer patients from 10 Latin American countries were screened for inclusion. ALKr detection was performed by fluorescence in situ hybridization (FISH), immunohistochemistry (IHC), and real-time reverse transcriptase-polymerase chain reaction (RT-PCR) to assess method variability. Demographic and clinicopathologic characteristics were analyzed. Results: Among the 5,130 patients screened, 8.4% (n = 433) had nonevaluable FISH tests. Evaluable FISH analyses revealed positive ALKr in 6.8% (320/4,697) of the study population, which included patients from 9 countries. ALKr distribution for each country was: Mexico 7.6% (79/1,034), Colombia 4.1% (10/242), Argentina 6.0% (153/2,534), Costa Rica 9.5% (13/137), Panama 4.4% (5/114), Uruguay 5.4% (2/37), Chile 8.6% (16/185), Venezuela 8.9% (13/146), and Peru 10.8% (29/268). RT-PCR showed high positive (83.6%) and negative (99.7%) predictive values when compared to the gold standard FISH. In contrast, IHC only showed a high negative predictive value (94.6%). Conclusions: Although there is a clear country and continental variability in terms of ALKr frequency, this difference is not significant and the overall incidence of ALKr in Latin America does not differ from the rest of the world.

History

Usage metrics

    Oncology

    Categories

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC